Sartorius Stedim Biotech S.A.
SDMHF | OTC
$248.00
-$6.56 (-2.58%)
At close: Oct 30, 2026, 10:10 AM ET
$248.00
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 76.92 | 104.25 | 71.28 | 31.81 | 107.20 | 80 |
PEG Ratio | 1.51 | -2.26 | -1.10 | 0.29 | 4.54 | 1.85 |
PS Ratio | 6.89 | 6.57 | 7.95 | 7.98 | 15.40 | 14.05 |
PB Ratio | 5 | 4.58 | 8.37 | 11.38 | 26.85 | 18.38 |
P/FCF Ratio | 140.53 | 38.42 | 141.40 | 153.44 | 119.54 | 104.17 |
P/OCF Ratio | 37.94 | 22.40 | 35.05 | 45.53 | 63.89 | 64.39 |
OCF/S Ratio | 18.15 | 29.32 | 22.69 | 17.53 | 24.11 | 21.83 |
Debt / Equity Ratio | 0.64 | 0.72 | 1.40 | 0.46 | 0.38 | 0.40 |
Quick Ratio | 0.53 | 1.12 | 0.57 | 0.62 | 0.65 | 0.71 |
Current Ratio | 1.02 | 1.85 | 1.51 | 1.61 | 1.40 | 1.54 |
Asset Turnover | 0.37 | 0.34 | 0.36 | 0.69 | 0.73 | 0.62 |
Interest Coverage | 3.60 | 2.33 | 4 | 26.86 | 38.54 | 12.51 |
Return on Equity | 6.49% | 4.39% | 11.74% | 35.77% | 25.03% | 23.01% |
Return on Assets | 3.31% | 2.12% | 4% | 17.30% | 10.49% | 10.94% |
Return on Invested Capital | 5.44% | 4.09% | 5.48% | 21.15% | 19.79% | 13.95% |
Dividend Yield | 0.33% | 0.37% | 0.60% | 0.42% | 0.14% | 0.12% |
Payout Ratio | 25.26% | 38.32% | 42.85% | 13.25% | 15.13% | 9.33% |
FCF Payout Ratio | 46.15% | 14.12% | 85.01% | 63.90% | 16.89% | 12.20% |
Gross Profit Margin | 45.33% | 43.41% | 44.44% | 52.03% | 53.79% | 52.50% |
Net Profit Margin | 8.95% | 6.30% | 11.16% | 25.08% | 14.35% | 17.59% |
Pretax Profit Margin | 12.58% | 7.88% | 14.45% | 32.36% | 22.40% | 25.27% |
Operating Profit Margin | 18.50% | 13.33% | 17.46% | 31.53% | 31.61% | 24.70% |
FCF Margin | 4.90% | 17.10% | 5.62% | 5.20% | 12.88% | 13.49% |
EBITDA Margin | 29.22% | 24.12% | 27.23% | 38.10% | 28.12% | 29.80% |
Add to Watchlist
Select watchlists to add or remove SDMHF